Infections in Systemic Autoimmune Diseases

Infections in Systemic Autoimmune Diseases

Risk Factors and Management

1st Edition - March 8, 2020
This is the Latest Edition
  • Editors: Fabiola Atzeni, Massimo Galli, Juan Gomez Reino, James Galloway
  • eBook ISBN: 9780444642189
  • Paperback ISBN: 9780444642172

Purchase options

Purchase options
DRM-free (EPub, PDF, Mobi)
Available
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Infections in Systemic Autoimmune Diseases: Risk Factors and Management, Volume Sixteen describes the state-of-the-art of the risk factors and management treating the most common systemic autoimmune diseases (SADS). This updated volume consists of an introductory chapter that provides a brief overview of what different types of infectious diseases exist, followed by eight chapters detailing risk factors, guidelines and recommendations per different disease and bacterial infections. International in scope, the list of more than 20 contributors from Europa and America reads like a who’s who of clinical researchers in the field.

Key Features

  • Written by leading international clinical/surgical and scientific experts on Infection problems in systemic autoimmune diseases
  • Provides a practical guide to the safer treatment of infections in patients with autoimmune diseases
  • Includes a number of problems and recommendation that cannot be found in other books
  • Designed as a ‘guide to clinical practice’ for management and risk interventions required by patients with SAD’s

Readership

Immunologists, rheumatologists, hematologists, cardiologists, postgraduate students and those working in autoimmune diseases, general medicine and hospital/pharmaceutical management

Table of Contents

  • 1. The spectrum of infectious diseases
    1.2. Hepatitis
    1.2. 1. Hepatitis A;E
    1.2. 2. Hepatitis C
    1.2. 3. Hepatitis B, D
    1.3. Herpes Zoster infections
    1.4 HIV infections
    1.4. TB and atypical mycobacterias
    1.5. Bacterial infections
    1.6 Non-mycobacterial opportunistic diseases

    2. Comorbidities in patients with rheumatic disease

    3. Drugs used in rheumatic disease

    4. Risk/benefit management in the infectious phase.

    5. Vaccine recommedations in patients with systemic rheumatic diseases

    6. Education for patients/family and doctors

Product details

  • No. of pages: 228
  • Language: English
  • Copyright: © Elsevier 2020
  • Published: March 8, 2020
  • Imprint: Elsevier
  • eBook ISBN: 9780444642189
  • Paperback ISBN: 9780444642172

About the Series Volume Editors

Fabiola Atzeni

Fabiola Atzeni
Fabiola Atzeni is currently a Specialist in Rheumatology and Ph.D. in Experimental Immunology by the University of Barcelona. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has (co)authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals Arthritis Research Therapy, Journal of Rheumatology and PlosOne, Lupus, Clinical Experimental. She is involved in several (international/national) meetings focused on cardiovascular and infection aspects in rheumatic disease.

Affiliations and Expertise

Specialist in Rheumatology, Experimental Immunology, University of Barcelona, Barcelona, Catalonia, Spain

Massimo Galli

Massimo is Doctor of medicine at the University of Milan. And director of the department of infectious diseases

Affiliations and Expertise

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan/UNIMI, Milan, Italy

Juan Gomez Reino

Professor Juan Jose Gomez Reino MD is head of the rheumatology department at the University of Santiago. Juan obtained his MD and PhD from the Autonomous University of Madrid, he undertook his post doc training at the New York State University , Stony Brook USA. His clinical research mainly focuses on the search for improved treatments for Rheumatoid Arthrosis and Atherosclerosis which has resulted in many clinical treatment solutions.

Affiliations and Expertise

Complejo Hospitalario Universitario de Santiago, Servicio de Reumatología, Travesia da Choupana, Santiago de Compostela, 15706, SPAIN

James Galloway

Dr Galloway is a clinical lecturer at King's College London and an honorary consultant in rheumatology at King's College Hospital. He runs the biologics assessment service for the rheumatology department. His research background has been in the study of biologic therapy safety. Within his role for KCL he works in the CRC accredited King's Clinical Trials Unit which has a large portfolio of investigator led trials. He also runs a phase 1 clinic in collaboration with the BRC facility and the Quintiles MHRA accredited Early Phase clinical trials unit at Guy's Hospital.

Affiliations and Expertise

Kings College, London, UK